logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-37. Amphetamines and ecstasy clients entering drug treatment, 2007 or most recent year available [see all tables in this series...]

Part (ii) Outpatient clients by primary drug and mean age and gender ratio

Primary drugMean ageGender ratio


 Countries providing data: BE, BG, CZ, DK, IE, EL, ES, FR, IT, CY , LU, HU, MT, NL, AT, RO, SI, SK, FI, SE, UK, HR 

 Data for Spain and Malta refer to 2006. Data for Belgium refer to 2005. 

 The number of treatment clients in each country is listed in <a href="https://www.emcdda.europa.eu/stats07/tditab7">Table TDI-7</a>. 

 See also 'General notes for interpreting data’ on the <a href="https://www.emcdda.europa.eu/stats07/help">Explanatory notes and help page</a>. 


 <a href="https://www.emcdda.europa.eu/publications/national-reports">Reitox national reports 2008</a> — Standard table 3. See <a href="https://www.emcdda.europa.eu/stats08/tditab0">Table TDI-0</a> for details on sources. See also TDI-5. 

(see the help page for information about formats etc.)

Page last updated: Tuesday, 21 July 2009